Aflac stock has delivered a strong 130.6% return over the past 5 years, yet investors now face mixed valuation signals as the Excess Returns intrinsic value estimate points to meaningful upside while earnings based multiples lean the other way. The current checks suggest Aflac is neither a clear bargain nor obviously overpriced, which puts more focus on how you think the cash generation story will develop.
- Over the last 5 years, Aflac has returned 130.6%, which means recent shareholders have already seen substantial value created from the starting point.
- Future cash flow expectations and the resilience of Aflac's insurance margins can support the current share price, while any sustained pressure on claims costs or investment income may weigh on what investors are willing to pay.
- Aflac scores 3 out of 6 on our valuation checks, which is a mixed picture rather than a clean signal that the stock is cheap or expensive.
The issue now is whether Aflac's current price offers a reasonable margin of safety given the gap between the intrinsic value estimate and the market's earnings multiple view.
Is Aflac Still Cheap on Excess Returns?
The Excess Returns model evaluates how much value Aflac creates above the required return on shareholder equity. For Aflac, the key inputs point to a business that is expected to keep generating earnings comfortably above its equity cost.
The model uses a Book Value of $60.35 per share and a Stable EPS estimate of $8.23 per share, based on weighted future Return on Equity estimates from 5 analysts. With a Cost of Equity of $4.46 per share and an Excess Return of $3.77 per share, Aflac’s average Return on Equity of 13.34% sits above what the model requires. A stable Book Value of $61.70 per share, sourced from 7 analyst forecasts, helps support an intrinsic value estimate of $168.20 per share. This comparison suggests the current market price implies a sizable discount.
On this Excess Returns view, Aflac stock screens as undervalued relative to the cash returns its equity base is expected to generate.
Our Excess Returns analysis suggests Aflac is undervalued by 30.9%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.
Does Aflac Look Pricey on Earnings?
P/E is a useful lens for Aflac because earnings are a primary driver of value for a mature insurer with an established book of business. It helps you see what the market is currently willing to pay for each dollar of Aflac’s earnings.
Aflac trades on a P/E of about 12.0x, which is slightly above the Insurance industry average of 11.2x and below the broader peer group average of 15.7x. The tailored fair P/E for Aflac is 10.0x, which reflects what would be expected given its margins, risk profile and size. The current market price therefore embeds a premium of around 2 turns of earnings relative to that fair multiple.
This gap suggests investors are paying up a little more than the model implies is warranted on earnings alone, even if the stock is not stretched compared with some peers.
On the P/E lens, Aflac stock currently screens as overvalued relative to the earnings multiple that the fair ratio model suggests.
See what the numbers say about this price — find out in our valuation breakdown.
The Aflac Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Aflac pick up where this valuation puzzle leaves off and set out the specific earnings, margin and growth paths that would need to play out for Aflac's stock to be worth materially more or materially less than it is today. Rather than giving a single figure, they unpack the future that figure rests on so you can watch how Aflac's actual progress lines up with those assumptions over time on the Community page.
You can add your voice to the Aflac story by sharing a Narrative that sets out your number driven view on where its growth, margins and execution go from here. Put your case on the record in the Simply Wall St community and see how it holds up as new results come through.
Do you think there's more to the story for Aflac? Head over to our Community to see what others are saying!
The Bottom Line
The Excess Returns intrinsic value estimate points to Aflac stock trading at a discount, while the earnings multiple view flags it as slightly overvalued on P/E. That split reflects different lenses. Intrinsic value focuses on how efficiently Aflac is expected to turn its equity base into cash returns, while the multiple view reflects what the market is prepared to pay for those earnings relative to peers. With the broader valuation checks landing in a mixed zone, the key question is whether Aflac can sustain its return on equity and cash generation strongly enough to ease concerns about paying a premium P/E.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com